20 years of revenue, earnings, cash-flow and balance-sheet history from public filings.
GH Research PLC (GHRS) operates in the BIOTECHNOLOGY industry and is headquartered in Dublin, Ireland with about 73 employees. Its market capitalization is roughly $2 billion. In the fiscal year ended 2025-12-31, GHRS reported $0M in revenue and ($48M) in net income.
GH Research PLC, together with its subsidiary, operates a clinical-stage biopharmaceutical company that develops treatments for depression in the United States.
Interactive charts & full statements →
| Income statement | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $0M |
| Gross Profit | — | $0M | $0M | $0M | $0M | $0M | — | — |
| Gross Margin % | — | — | — | — | — | — | — | — |
| Operating Income (EBIT) | ($71M) | ($61M) | ($50M) | ($41M) | ($31M) | ($15M) | $0M | $0M |
| Operating Margin % | — | — | — | — | — | — | — | — |
| Net Income | ($62M) | ($48M) | ($39M) | ($36M) | ($22M) | ($9M) | $0M | $0M |
| Net Margin % | — | — | — | — | — | — | — | — |
| EBITDA | ($64M) | ($47M) | ($39M) | ($35M) | ($22M) | ($9M) | $0M | $0M |
| Earnings Per Share (EPS) | $-0.99 | $-0.79 | $-0.75 | $-0.68 | $-0.43 | $-0.18 | $-0.01 | $-0.01 |
| Shares Outstanding (M) | 67M | 61M | 52M | 52M | 52M | 52M | 30M | 28M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly income statement | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Total Revenue | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $0M |
| Gross Profit | — | $0M | $0M | $0M | $0M | $0M | $0M | $0M |
| Gross Margin % | — | — | — | — | — | — | — | — |
| Operating Income (EBIT) | ($19M) | ($19M) | ($17M) | ($17M) | ($15M) | ($13M) | ($13M) | ($13M) |
| Operating Margin % | — | — | — | — | — | — | — | — |
| Net Income | ($15M) | ($19M) | ($14M) | ($14M) | ($9M) | ($11M) | ($9M) | ($12M) |
| Net Margin % | — | — | — | — | — | — | — | — |
| EBITDA | ($15M) | ($19M) | ($17M) | ($14M) | ($9M) | ($11M) | ($9M) | ($12M) |
| Earnings Per Share (EPS) | $-0.23 | $-0.31 | $-0.23 | $-0.23 | $-0.15 | $-0.19 | $-0.17 | $-0.23 |
| Shares Outstanding (M) | 67M | 62M | 62M | 62M | 62M | 58M | 52M | 52M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Cash flow | TTM → 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($52M) | ($44M) | ($42M) | ($33M) | ($26M) | ($15M) | $0M | $0M |
| Capital Expenditures (CapEx) | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $0M |
| Free Cash Flow (FCF) | ($53M) | ($44M) | ($42M) | ($33M) | ($26M) | ($15M) | $0M | $0M |
| FCF Margin % | — | — | — | — | — | — | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Quarterly cash flow | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 | 2025-03-31 | 2024-12-31 | 2024-09-30 |
|---|---|---|---|---|---|---|---|---|
| Cash from Operations (CFO) | ($15M) | ($11M) | ($12M) | ($14M) | ($9M) | ($9M) | ($10M) | ($12M) |
| Capital Expenditures (CapEx) | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $0M |
| Free Cash Flow (FCF) | ($15M) | ($11M) | ($12M) | ($14M) | ($9M) | ($9M) | ($10M) | ($12M) |
| FCF Margin % | — | — | — | — | — | — | — | — |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
| Balance sheet | 2026-06-30 | 2025-12-31 | 2024-12-31 | 2023-12-31 | 2022-12-31 | 2021-12-31 | 2020-12-31 | 2019-12-31 |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $372M | $288M | $188M | $226M | $254M | $280M | $6M | $1M |
| Cash & Cash Equivalents | $345M | $246M | $101M | $78M | $166M | $277M | $6M | $0M |
| Total Liabilities | $13M | $9M | $9M | $7M | $5M | $3M | $0M | $0M |
| Total Debt (Short + Long-Term) | $0M | $0M | $0M | $0M | $0M | $0M | $0M | $0M |
| Total Shareholders' Equity | $359M | $280M | $179M | $219M | $250M | $277M | $6M | $0M |
USD; $M / $B as marked. Newest period first. Source: public company filings (via Yahoo Finance aggregation).
Quarterly statements, profitability ratios, price history, insider activity and institutional holders are in the interactive GHRS viewer.
About TickerBase · Data methodology & sources · Privacy · Terms